Top

Published in:

Open Access 01-12-2011 | Review

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions

Authors: Andrea L Ciaranello, Ji-Eun Park, Lynn Ramirez-Avila, Kenneth A Freedberg, Rochelle P Walensky, Valeriane Leroy

Published in: BMC Medicine | Issue 1/2011

Abstract

Early infant diagnosis (EID) of HIV-1 infection confers substantial benefits to HIV-infected and HIV-uninfected infants, to their families, and to programs providing prevention of mother-to-child transmission (PMTCT) services, but has been challenging to implement in resource-limited settings. In order to correctly inform parents/caregivers of infant infection status and link HIV-infected infants to care and treatment, a 'cascade' of events must successfully occur. A frequently cited barrier to expansion of EID programs is the cost of the required laboratory assays. However, substantial implementation barriers, as well as personnel and infrastructure requirements, exist at each step in the cascade. In this update, we review challenges to uptake at each step in the EID cascade, highlighting that even with the highest reported levels of uptake, nearly half of HIV-infected infants may not complete the cascade successfully. We next synthesize the available literature about the costs and cost effectiveness of EID programs; identify areas for future research; and place these findings within the context of the benefits and challenges to EID implementation in resource-limited settings.

Available only for authorised users

UNAIDS/UNICEF/WHO: Children and AIDS: Fourth stocktaking report, actions and progress. [http://www.unicef.org/publications/index_46585.html]

World Health Organization: Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Progress Report. [http://www.who.int/hiv/pub/2010progressreport/report/en/index.html]

Creek T, Tanuri A, Smith M, Seipone K, Smit M, Legwaila K, Motswere C, Maruping M, Nkoane T, Ntumy R, Bile E, Mine M, Lu L, Tebele G, Mazhani L, Davis MK, Roels TH, Kilmarx PH, Shaffer N: Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission. Pediatr Infect Dis J. 2008, 27: 22-26. 10.1097/INF.0b013e3181469050.CrossRefPubMed

Sherman GG, Matsebula TC, Jones SA: Is early HIV testing of infants in poorly resourced prevention of mother to child transmission programmes unaffordable?. Trop Med Int Health. 2005, 10: 1108-1113. 10.1111/j.1365-3156.2005.01495.x.CrossRefPubMed

Barker PM, Mphatswe W, Rollins N: Antiretroviral drugs in the cupboard are not enough: the impact of health Systems' performance on mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2010, 56: e45-48.CrossRef

World Health Organization: Antiretroviral therapy for HIV infection in infants and children: Recommendations for a public health approach (2010 version). [http://www.who.int/hiv/pub/paediatric/infants2010/en/index.html]

Chantry CJ, Cooper ER, Pelton SI, Zorilla C, Hillyer GV, Diaz C: Seroreversion in human immunodeficiency virus-exposed but uninfected infants. Pediatr Infect Dis J. 1995, 14: 382-387. 10.1097/00006454-199505000-00009.CrossRefPubMed

Sohn A, Le Q, Truong X, Le T, Truong H, Wara D, Cachafeiro A, Rutherford G: Abstract 670: The utrasensitive p24 antigen assay is comparable to DNA PCR for early infant diagnosis, Ho Chi Minh City, Vietnam. Conference on Retroviruses and Opportunistic Infections. Los Angeles. 2007, [http://www.retroconference.org/2007/Abstracts/28425.htm]

Dabis F, Msellati P, Dunn D, Lepage P, Newell M, Peckham C, Van de Perre P, the Working Group on Mother-to-Child Transmission of HIV: Estimating the rate of mother-to-child transmission of HIV. Report of a workshop on methodological issues; Ghent (Belgium), 17-20 February 1992. AIDS. 1993, 7: 1139-1148. 10.1097/00002030-199308000-00027.CrossRefPubMedPubMedCentral

10.

World Health Organization: Antiretroviral therapy of HIV infection in infants and children: towards universal access. Recommendations for a public health approach. [http://www.who.int/hiv/pub/guidelines/art/en/index.html]

11.

Creek TL, Sherman GG, Nkengasong J, Lu L, Finkbeiner T, Fowler MG, Rivadeneira E, Shaffer N: Infant human immunodeficiency virus diagnosis in resource-limited settings: issues, technologies, and country experiences. Am J Obstet Gynecol. 2007, 197: S64-71.CrossRefPubMed

12.

Read JS: Diagnosis of HIV-1 infection in children younger than 18 months in the United States. Pediatrics. 2007, 120: e1547-1562. 10.1542/peds.2007-2951.CrossRefPubMed

13.

Lambert JS, Harris DR, Stiehm ER, Moye J, Fowler MG, Meyer WA, Bethel J, Mofenson LM: Performance characteristics of HIV-1 culture and HIV-1 DNA and RNA amplification assays for early diagnosis of perinatal HIV-1 infection. J Acquir Immune Defic Syndr. 2003, 34: 512-519. 10.1097/00126334-200312150-00011.CrossRefPubMed

14.

Young NL, Shaffer N, Chaowanachan T, Chotpitayasunondh T, Vanparapar N, Mock PA, Waranawat N, Chokephaibulkit K, Chuachoowong R, Wasinrapee P, Mastro TD, Simonds RJ, Bangkok Collaborative Perinatal HIV Transmission Study Group: Early diagnosis of HIV-1-infected infants in Thailand using RNA and DNA PCR assays sensitive to non-B subtypes. J Acquir Immune Defic Syndr. 2000, 24: 401-407.CrossRefPubMed

15.

Nielsen K, Bryson YJ: Diagnosis of HIV infection in children. Pediatr Clin North Am. 2000, 47: 39-63. 10.1016/S0031-3955(05)70194-2.CrossRefPubMed

16.

Owens DK, Holodniy M, McDonald TW, Scott J, Sonnad S: A meta-analytic evaluation of the polymerase chain reaction for the diagnosis of HIV infection in infants. JAMA. 1996, 275: 1342-1348. 10.1001/jama.275.17.1342.CrossRefPubMed

17.

Dunn DT, Brandt CD, Krivine A, Cassol SA, Roques P, Borkowsky W, De Rossi A, Denamur E, Ehrnst A, Loveday C: The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. AIDS. 1995, 9: F7-11.CrossRefPubMed

18.

Garcia-Prats A, Draper H, Sanders J, Agrawal A, Mohapi E, Schutze G: Post-18 month confirmatory HIV testing in HIV DNA PCR positive children: retrospective descriptive analysis from an operational setting in Lesotho. 2010, International AIDS Society. Vienna, Austria, [http://pag.aids2010.org/Abstracts.aspx?SID=644&AID=17231]

19.

Eberle J, Notheis G, Blattmann C, Jung J, Buchholz B, Korn K, Kulozik AE, Schnitzler P: Seroreversion in vertically HIV-1-infected children treated early and efficiently: rule or exception?. AIDS. 24: 2760-2761.

20.

Patton JC, Coovadia AH, Meyers TM, Sherman GG: Evaluation of the ultrasensitive human immunodeficiency virus type 1 (HIV-1) p24 antigen assay performed on dried blood spots for diagnosis of HIV-1 infection in infants. Clin Vaccine Immunol. 2008, 15: 388-391. 10.1128/CVI.00265-07.CrossRefPubMed

21.

Fiscus SA, Wiener J, Abrams EJ, Bulterys M, Cachafeiro A, Respess RA: Ultrasensitive p24 antigen assay for diagnosis of perinatal human immunodeficiency virus type 1 infection. J Clin Microbiol. 2007, 45: 2274-2277. 10.1128/JCM.00813-07.CrossRefPubMedPubMedCentral

22.

Knuchel MC, Jullu B, Shah C, Tomasik Z, Stoeckle MP, Speck RF, Nadal D, Mshinda H, Böni J, Tanner M, Schüpbach J: Adaptation of the ultrasensitive HIV-1 p24 antigen assay to dried blood spot testing. J Acquir Immune Defic Syndr. 2007, 44: 247-253. 10.1097/QAI.0b013e31802c3e67.CrossRefPubMed

23.

Jangam S, McFall S, Yamada D, Sur K, Agarwal A, Wagner R, Kelso D: Abstract 891: A point-of-care DNA PCR test for infants. 2010, Conference on Retroviruses and Opportunistic Infections. San Francisco, [http://retroconference.org/2010/Abstracts/39114.htm]

24.

Parpia Z, Elghanian R, Nabatiyan A, Hardie D, Kelso D: Abstract 968: Evaluation of a rapid lateral flow p24 assay for the diagnosis of HIV in infants. 2009, Conference on Retroviruses and Opportunistic Infections. Montreal, Canada, [http://www.retroconference.org/2009/Abstracts/36378.htm]

25.

Cachafeiro A, Sherman GG, Sohn AH, Beck-Sague C, Fiscus SA: Diagnosis of human immunodeficiency virus type 1 infection in infants by use of dried blood spots and an ultrasensitive p24 antigen assay. J Clin Microbiol. 2009, 47: 459-462. 10.1128/JCM.01181-08.CrossRefPubMed

26.

Wittawatmongkol O, Vanprapar N, Chearskul P, Phongsamart W, Prasitsuebsai W, Sutthent R, Chokephaibulkit K: Boosted p24 antigen assay for early diagnosis of perinatal HIV infection. J Med Assoc Thai. 2010, 93: 187-190.PubMed

27.

Parpia ZA, Elghanian R, Nabatiyan A, Hardie DR, Kelso DM: p24 antigen rapid test for diagnosis of acute pediatric HIV infection. J Acquir Immune Defic Syndr. 2010, 55: 413-419. 10.1097/QAI.0b013e3181f1afbc.CrossRefPubMed

28.

Lofgren SM, Morrissey AB, Chevallier CC, Malabeja AI, Edmonds S, Amos B, Sifuna DJ, von Seidlein L, Schimana W, Stevens WS, Bartlett JA, Crump JA: Evaluation of a dried blood spot HIV-1 RNA program for early infant diagnosis and viral load monitoring at rural and remote healthcare facilities. AIDS. 2009, 23: 2459-2466. 10.1097/QAD.0b013e328331f702.CrossRefPubMedPubMedCentral

29.

Sherman GG, Jones SA: Oral fluid human immunodeficiency virus tests: improved access to diagnosis for infants in poorly resourced prevention of mother to child transmission programs. Pediatr Infect Dis J. 2005, 24: 253-256. 10.1097/01.inf.0000154325.85754.a3.CrossRefPubMed

30.

Mehta N, Trzmielina S, Nonyane BA, Eliot MN, Lin R, Foulkes AS, McNeal K, Ammann A, Eulalievyolo V, Sullivan JL, Luzuriaga K, Somasundaran M: Low-cost HIV-1 diagnosis and quantification in dried blood spots by real time PCR. PLoS One. 2009, 4: e5819-10.1371/journal.pone.0005819.CrossRefPubMedPubMedCentral

31.

Sherman G, Technau K, Kalk E, Hampton G, Khan S, Bhowan K, Selepe N, Barrie L, Carmona S, Goga A, Olorunju S, Manda S, Coovadia A: Earlier diagnosis of HIV infection in infants in low resource settings. 5th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, Abstract no. WEPEB267, [http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200721991]

32.

World Health Organization: Report of the WHO Technical Reference Group Pediatric HIV ART/Care Guideline Group Meeting. [http://www.who.int/hiv/pub/paediatric/WHO_Paediatric_ART_guideline_rev_mreport_2008.pdf]

33.

Violari A, Cotton MF, Gibb DM, Babiker AG, Steyn J, Madhi SA, Jean-Philippe P, McIntyre JA: CHER Study Team: Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008, 359: 2233-2244. 10.1056/NEJMoa0800971.CrossRefPubMedPubMedCentral

34.

Meyer-Rath G, Violari A, Cotton M, Ndibongo B, Brenna A, Long L, Panchia R, Coovadia A, Gibb DM, Rosen S: THLBB103: The cost of early vs. deferred paediatric antiretroviral treatment in South Africa - a comparative economic analysis of the first year of the CHER trial. 2010, International AIDS Society. Vienna, Austria, [http://pag.aids2010.org/Abstracts.aspx?SID=644&AID=17823]

35.

Chadwick EG, Rodman JH, Britto P, Powell C, Palumbo P, Luzuriaga K, Hughes M, Abrams EJ, Flynn PM, Borkowsky W, Yogev R: PACTG Protocol 345 Team: Ritonavir-based highly active antiretroviral therapy in human immunodeficiency virus type 1-infected infants younger than 24 months of age. Pediatr Infect Dis J. 2005, 24: 793-800. 10.1097/01.inf.0000177281.93658.df.CrossRefPubMed

36.

Chiappini E, Galli L, Tovo PA, Gabiano C, Gattinara GC, Guarino A, Badolato R, Giaquinto C, Lisi C, de Martino M: Italian Register for HIV Infection in Children: Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. AIDS. 2006, 20: 207-215. 10.1097/01.aids.0000200529.64113.3e.CrossRefPubMed

37.

Faye A, Le Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G, Lachassinne E, Levine M, Nicolas J, Monpoux F, Tricoire J, Rouzioux C, Tardieu M, Mayaux MJ, Blanche S, French Perinatal Study Group: Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis. 2004, 39: 1692-1698. 10.1086/425739.CrossRefPubMed

38.

Varga CA, Sherman GG, Maphosa J, Jones SA: Psychosocial consequences of early diagnosis of HIV status in vertically exposed infants in Johannesburg, South Africa. Health Care Women Int. 2005, 26: 387-397.CrossRefPubMed

39.

World Health Organization: Principles and recomendations for infant feeding in the context of HIV and a summary of evidence. [http://www.who.int/child_adolescent_health/documents/9789241599535/en/index.html]

40.

Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team: Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006, 296: 794-805. 10.1001/jama.296.7.794.CrossRefPubMed

41.

Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A, The Ethiopian Swen Study Team: Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to child HIV-transmission. AIDS Res Hum Retroviruses. 2011.

42.

Moorthy A, Gupta A, Bhosale R, Tripathy S, Sastry J, Kulkarni S, Thakar M, Bharadwaj R, Kagal A, Bhore AV, Patil S, Kulkarni V, Venkataramani V, Balasubramaniam U, Suryavanshi N, Ziemniak C, Gupte N, Bollinger R, Persaud D: Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One. 2009, 4: e4096-10.1371/journal.pone.0004096.CrossRefPubMedPubMedCentral

43.

World Health Organization: HIV and infant feeding: Revised Principles and Recommendations Rapid Advice. [http://whqlibdoc.who.int/publications/2009/9789241598873_eng.pdf]

44.

Kuhn L, Aldrovandi GM, Sinkala M, Kankasa C, Semrau K, Mwiya M, Kasonde P, Scott N, Vwalika C, Walter J, Bulterys M, Tsai WY, Thea DM: Zambia Exclusive Breastfeeding Study: Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008, 359: 130-141. 10.1056/NEJMoa073788.CrossRefPubMedPubMedCentral

45.

Becquet R ED, Menan H, Amani-Bosse C, Bequet L, Viho I, Dabis F, Timite-Konan M, Leroy V: Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire. Prevent Med. 2008, 47: 27-33. 10.1016/j.ypmed.2007.11.014.CrossRef

46.

Horwood C, Vermaak K, Rollins N, Haskins L, Nkosi P, Qazi S: Paediatric HIV management at primary care level: an evaluation of the integrated management of childhood illness (IMCI) guidelines for HIV. BMC Pediatr. 2009, 9: 59-10.1186/1471-2431-9-59.CrossRefPubMedPubMedCentral

47.

Iliff P, Ntozini R, Nathoo K, Piwoz E, Moulton L, ZVITAMBO Study Group, Humphrey J: Making a working clinical diagnosis of HIV infection in infants in Zimbabwe. Trop Med Int Health. 2008, 13: 1459-1469. 10.1111/j.1365-3156.2008.02178.x.CrossRefPubMed

48.

Kumar D, Aggarwal AK, Kumar R: The effect of interrupted 5-day training on integrated management of neonatal and childhood illness on the knowledge and skills of primary health care workers. Health Policy Plan. 2009, 24: 94-100. 10.1093/heapol/czn051.CrossRefPubMed

49.

Jaspan H, Myer L, Violari A, Madhi S, Steyn J, van Niekerk R, Stevens W, Cotton M: Abstract #76: Clinical and immunological characteristics of very young infants with HIV infection: Children with HIV Early Antiretroviral Study. Conference on Retroviruses and Opportunistic Infections. 2008, Boston, MA, [http://www.retroconference.org/2008/Abstracts/31111.htm]

50.

Arrivé E, Kyabayinze DJ, Marquis B, Tumwesigye N, Kieffer MP, Azondekon A, Wemin L, Fassinou P, Newell ML, Leroy V, Abrams EJ, Cotton M, Boulle A, Mbori-Ngacha D, Dabis F, KIDS-ART-LINC Collaboration: Cohort profile: The paediatric Antiretroviral Treatment Programmes in Lower-Income Countries (KIDS-ART-LINC) Collaboration. Int J Epidemiol. 2007, 37: 474-480.CrossRefPubMed

51.

Ciaranello A, Chang Y, Margulis A, Bernstein A, Bassett IV, Losina E, Walensky RP: Effectiveness of pediatric ART in resource-limited settings: a systematic review and meta-analysis. Clin Infect Dis. 2009, 49: 1915-1927. 10.1086/648079.CrossRefPubMedPubMedCentral

52.

UNAIDS/UNICEF/WHO: Children and AIDS: Third stocktaking report, actions and progress. [http://www.unicef.org/publications/index_46585.html]

53.

Akinwande O, Omoigberale A, Onakewhor J, Esene H, Chime C, Sadoh W, Enzama R, Farley J, Abimiku A: Abstract no. CDC011: Early infant diagnosis (EID) as a tool to assess PMTCT effectiveness and challenges 5th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, [http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200721554]

54.

Somlare H, Sangare L, Yamegogo S, Ouedraogo C, Dembel Y, Soro M, Some P, Yonaba C: Early diagnosis of HIV-1 infection in infants using RNA Quantitative PCR in Burkina Faso. Retrovirology. 2009, 6: P10.CrossRef

55.

Bolu O, Abutu A, Omeogu C, Nwude C, Akpan R, et al: Abstract 747: Benefits of routine HIV screening of sick children in Nigeria. The 2008 HIV/AIDS Implementers' Meeting. 2008, Kampala, Uganda, 47-[http://www.hivimplementers.com/2008/pdf/OGAC_08_BookHR.pdf]

56.

Gautney B, Segaren N, Khamadi S: Abstract no. CDA087: Private and public partnership: a model for a national HIV early infant diagnosis program in Haiti. 5th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, [http://www.ias2009.org/pag/Abstracts.aspx?AID=1654]

57.

Mushavi A, Dillavou C, Sawadogo S, Witbooi D, Gawanab M, Soroses F, Rusberg F: Abstract 1000, page 92: Namibia's early infant diagnosis program from January 2006 to September 2008. The 2009 HIV/AIDS Implementers' Meeting. 2009, Windhoek, Namibia, [http://www.hivimplementers.com/pdfs/FINALAbstractBook.pdf]

58.

Ncube B, Freeman R, Murtagh M, Peter T: Abstract no. LBPE1152: The global scale-up of early infant diagnosis by DNA PCR: lessons from a review of select country programs. AIDS 2008 - XVII International AIDS Conference. 2008, Mexico City, Mexico, International AIDS Society, Geneva, Switzerland

59.

Chouraya C, Mahdi MA, Kieffer MP, Lukhele B: Abstract no. CDB078: Implementing early antiretroviral treatment for infants in Swaziland 5^th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, [http://www.ias2009.org/pag/Abstracts.aspx?AID=2545]

60.

Gidada BG, Ashenafi A, Negash Y, Ruff A, Wegderes H, Tesema M, Doherty M: Abstract 1286, page 137: EID program scale up and partnership with regional laboratories for sustainability. The 2009 HIV/AIDS Implementers' Meeting. 2009, Windhoek, Namibia, [http://www.hivimplementers.com/pdfs/FINALAbstractBook.pdf]

61.

Khamadi S, Okoth V, Lihana R, Nabwera J, Hungu J, Okoth F, Lubano K, Mwau M: Rapid identification of infants for antiretroviral therapy in a resource poor setting: the Kenya experience. J Trop Pediatr. 2008, 54: 370-374. 10.1093/tropej/fmn036.CrossRefPubMed

62.

Kimario CJ, Schimana W, Charles D, Teri IE, Giphart A, Marlinc R, McCullough R, Lee S, VantPadBosch J: Abstract 887, page 79: Scale up of early infant diagnosis (EID) in Tanzania: experience from the Elizabeth Glaser Pediatric AIDS Foundation. The 2009 HIV/AIDS Implementers' Meeting. 2009, Windhoek, Namibia, [http://www.hivimplementers.com/pdfs/FINALAbstractBook.pdf]

63.

Kouakou J, Nobah MT, Tanoh A, Fassinou P, Essombo J: Abstract no. MOPE0217, page 103: Preliminary results of the demonstration phase of routine early HIV testing of HIV-exposed infants identified through PMTCT programs in Côte d'Ivoire. AIDS 2008 - XVII International AIDS Conference. 2008, Mexico City, Mexico, [http://www.aids2008-abstracts.org/aids2008_book_vol1_web.pdf]

64.

Kouakou JS, Nobah M, Tanoh AR, Fassinou P, Borget M, Noba V, Aghokeng A, Rivadeneira E, Ou C, Dao H: Abstract 1645, page 135: Routine early HIV testing of HIV-exposed infants in PMTCT programs in Côte d'Ivoire. The 2008 HIV/AIDS Implementers' Meeting. 2008, Kampala, Uganda, [http://www.hivimplementers.com/2008/pdf/OGAC_08_BookHR.pdf]

65.

Mahdi MA, Chouraya C, Waligo A, Shabalat F, Kieffer MP: Abstract no. MOPE0223, page 104: Early infant diagnosis (EID): Swaziland experience. AIDS 2008 - XVII International AIDS Conference. 2008, Mexico City, Mexico, [http://www.aids2008-abstracts.org/aids2008_book_vol1_web.pdf]

66.

Menzies NA, Homsy J, Chang Pitter JY, Pitter C, Mermin J, Downing R, Finkbeiner T, Obonyo J, Kekitiinwa A, Tappero J, Blandford JM: Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings. Pediatr Infect Dis J. 2009, 28: 819-825. 10.1097/INF.0b013e3181a3954b.CrossRefPubMed

67.

Nyathi M, Ndebele W, Ndebele B, Mbizvo E, Mudzori J, et al: Abstract no. CDB0442: Recruitment of infants for early infant diagnosis of HIV using DNA PCR testing in Zimbabwe: lessons learned from a national pilot project. AIDS 2008 - XVII International AIDS Conference. 2008, Mexico City, Mexico, International AIDS Society, Geneva, Switzerland

68.

Rollins N, Mzolo S, Moodley T, Esterhuizen T, van Rooyen H: Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009, 23: 1851-1857. 10.1097/QAD.0b013e32832d84fd.CrossRefPubMed

69.

Sundaram M, Lukhele B: Abstract no. MOPDD103: Identification patient loss points from testing to treatment initiation among infants tested in Swaziland. 5th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, [http://www.ias2009.org/pag/Abstracts.aspx?AID=1981]

70.

Nuwagaba-Biribonwoha H, Werq-Semo B, Abdallah A, Cunningham A, Gamaliel JG, Mtunga S, Nankabirwa V, Malisa I, Gonzalez LF, Massambu C, Nash D, Justman J, Abrams EJ: Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in Tanzania. BMC Pediatr. 2010, 10: 44-10.1186/1471-2431-10-44.CrossRefPubMedPubMedCentral

71.

Dow A, Dube Q, Chirambo CM, Moore M, Heyderman R, Van Rie A: Abstract no. CDB098: Community based early infant testing and treatment: experience from Blantyre, Malawi 5^th IAS Conference on HIV Pathogenesis and Treatment. 2009, Cape Town, South Africa, [http://www.iasociety.org/Default.aspx?pageId=11&abstractId=200721828]

72.

Guay L: SUSS03: Scaling up early infant diagnosis as the bridge between prevention, care, and treatment. 2010, International AIDS Society. Vienna, [http://pag.aids2010.org/session.aspx?s=150]

73.

Kellerman S, Essajee S: HIV testing for children in resource-limited settings: what are we waiting for?. PloS Med. 2010, 7: 285-285.CrossRef

74.

Mugwagwa R: The Child Health Card as a linkage tool: experiences from Zimbabwe. 2009, International AIDS Society. Cape Town, South Africa, [http://www.docstoc.com/docs/55372155/Issues-around-pre-test-revised-C]

75.

Evjen-Olsen B, Olsen OE, Kvale G: Achieving progress in maternal and neonatal health through integrated and comprehensive healthcare services - experiences from a programme in northern Tanzania. Int J Equity Health. 2009, 8: 27-10.1186/1475-9276-8-27.CrossRefPubMedPubMedCentral

76.

Hassan AS, Sakwa EM, Nabwera HM, Taegtmeyer MM, Kimutai RM, Sanders EJ, Awuondo KK, Mutinda MN, Molyneux CS, Berkley JA: Dynamics and constraints of early infant diagnosis of HIV infection in rural Kenya. AIDS Behav.

77.

Lu L, Legwaila K, Motswere C, Smit M, Jimbo W, Creek T: Abstract 91: HIV incidence in pregnancy and the first post-partum year and implications for PMTCT programs, Francistown, Botswana, 2008. Conference on Retroviruses and Opportunistic Infections. Montreal. 2009, [http://retroconference.org/2009/Abstracts/34193.htm]

78.

Dunn DT, Newell ML, Ades AE, Peckham CS: Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992, 340: 585-588. 10.1016/0140-6736(92)92115-V.CrossRefPubMed

79.

Wanyenze RK, Nawavvu C, Ouma J, Namale A, Colebunders R, Kamya MR: Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable. Trop Med Int Health. 2010, 15: 113-119.PubMed

80.

Weigel R, Kamthunzi P, Mwansambo C, Phiri S, Kazembe PN: Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre-post comparison. BMC Pediatr. 2009, 9: 80-10.1186/1471-2431-9-80.CrossRefPubMedPubMedCentral

81.

Leroy V BH, Oga M, Yapo V, Bosse-Amani C, Dago-Akribi H, Menan H, Ekouevi D, Timite-Konan M: Family acceptability of pediatric HIV counseling and testing offered routinely during postnatal care for children under 6 months of age, in Abidjan, Côte d'Ivoire. 2009, International AIDS Society. Cape Town, South Africa, [http://www.ias2009.org/pag/Abstracts.aspx?AID=2290]

82.

Rollins N, Little K, Mzolo S, Horwood C, Newell ML: Surveillance of mother-to-child transmission prevention programmes at immunization clinics: the case for universal screening. AIDS. 2007, 21: 1341-1347. 10.1097/QAD.0b013e32814db7d4.CrossRefPubMed

83.

Forum for Collaborative HIV Research: HIV Diagnostic and Monitoring Technologies in Resource Limited Settings. 2009, Washington, D.C., [http://www.hivforum.org/index.php?option=com_content&task=view&id=278&Itemid=65]

84.

Douglas GP, Gadabu OJ, Joukes S, Mumba S, McKay MV, Ben-Smith A, Jahn A, Schouten EJ, Landis Lewis Z, van Oosterhout JJ, Allain TJ, Zachariah R, Berger SD, Harries AD, Chimbwandira F: Using touchscreen electronic medical record systems to support and monitor national scale-up of antiretroviral therapy in Malawi. PLoS Med. 2010, 7: e1000319-10.1371/journal.pmed.1000319.CrossRefPubMedPubMedCentral

85.

Creek T: Early infant diagnosis in Botswana: Program and data use HIV Diagnostic and Monitoring Technologies in Resource Limited Settings. 2009, Washington, D.C., [http://www.hivforum.org/index.php?option=com_content&task=view&id=278&Itemid=65]

86.

Horwood C, Haskins L, Vermaak K, Phakathi S, Subbaye R, Doherty T: Prevention of mother to child transmission of HIV (PMTCT) programme in KwaZulu-Natal, South Africa: an evaluation of PMTCT implementation and integration into routine maternal, child and women's health services. Trop Med Int Health.

87.

Parpia Z, Elghanian R, Nabatiyan A, Hardie D, Kelso D: Abstract 892: Evaluation of a carbon nanoparticle-based rapid p24 assay for the diagnosis of HIV in infants: results from Cape Town. Conference on Retroviruses and Opportunistic Infections. San Francisco. 2010, [http://retroconference.org/2010/Abstracts/39264.htm]

88.

Losina E, Bassett IV, Giddy J, Chetty S, Regan S, Walensky RP, Ross D, Scott CA, Uhler LM, Katz JN, Holst H, Freedberg KA: The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South Africa. PLoS One. 2010, 5: e9538-10.1371/journal.pone.0009538.CrossRefPubMedPubMedCentral

89.

Augustinova D, Stranska A, Koum K, Ean S, Vong S, Kong C, Ngin S, Nerrienet E, Bandak M: Effectiveness of a district-wide programme for the prevention of mother-to-child transmission of HIV in Cambodia. Experience from six maternity units in Phnom Penh and Kandal. International AIDS Society. Cape Town, South Africa. 2009, [http://www.ias2009.org/pag/Abstracts.aspx?AID=2321]

90.

Creek T, Ntumy R, Mazhani L, Moore J, Smith M, Han G, Shaffer N, Kilmarx PH: Factors associated with low early uptake of a national program to prevent mother to child transmission of HIV (PMTCT): Results of a survey of mothers and providers, Botswana, 2003. AIDS Behav. 2009, 13: 356-364. 10.1007/s10461-007-9322-8.CrossRefPubMed

91.

Banda W, Mwenda R, Porter C, Yang C, Hersey S, Moyo H, Nyangulu L, Eliya M, Kamoto K, Demby A: Abstract 966, page 87: Establishing laboratory quality assurance for early infant diagnosis. The 2009 HIV/AIDS Implementers' Meeting. 2009, Windhoek, Namibia, [http://www.hivimplementers.com/pdfs/FINALAbstractBook.pdf]

92.

Gold MR, Siegel JE, Russell LB, Weinstein MC: Cost-Effectiveness in Health and Medicine. 1996, New York: Oxford University Press

93.

World Health Organization: WHO-CHOICE: Cost-effectiveness thresholds. [http://www.who.int/choice/costs/CER_thresholds/en/index.html]

94.

Maclean CC, Stringer JS: Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding. J Acquir Immune Defic Syndr. 2005, 38: 570-577. 10.1097/01.qai.0000142919.51570.88.CrossRefPubMed

95.

Aledort JE, Ronald A, Le Blancq SM, Ridzon R, Landay A, Rafael ME, Shea MV, Safrit J, Peeling RW, Hellmann N, Mwaba P, Holmes K, Wilfert C: Reducing the burden of HIV/AIDS in infants: the contribution of improved diagnostics. Nature. 2006, 444 (Suppl 1): 19-28.CrossRefPubMed

96.

Grobman WA, Garcia PM: The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. Am J Obstet Gynecol. 1999, 181: 1062-1071. 10.1016/S0002-9378(99)70082-7.CrossRefPubMed

97.

Rely K, Bertozzi SM, Avila-Figueroa C, Guijarro MT: Cost-effectiveness of strategies to reduce mother-to-child HIV transmission in Mexico, a low-prevalence setting. Health Policy Plan. 2003, 18: 290-298. 10.1093/heapol/czg035.CrossRefPubMed

98.

Chen KT, Sell RL, Tuomala RE: Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus-infected women(1). Obstet Gynecol. 2001, 97: 161-168. 10.1016/S0029-7844(00)01107-8.PubMed

99.

Stringer JS, Rouse DJ: Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis. Obstet Gynecol. 1999, 94: 34-40. 10.1016/S0029-7844(99)00243-4.PubMed

100.

Mrus JM, Yi MS, Eckman MH, Tsevat J: The impact of expected HIV transmission rates on the effectiveness and cost of ruling out HIV infection in infants. Med Decis Making. 2002, 22: S38-44. 10.1177/027298902237710.CrossRefPubMed

101.

Doyle NM, Levison JE, Gardner MO: Rapid HIV versus enzyme-linked immunosorbent assay screening in a low-risk Mexican American population presenting in labor: a cost-effectiveness analysis. Am J Obstet Gynecol. 2005, 193: 1280-1285. 10.1016/j.ajog.2005.07.001.CrossRefPubMed

102.

Agency for Healthcare Research and Quality: Screening for human immunodeficiency birus: focused update of a 2005 systematic evidence review for the U.S. Preventive Services Task Force. [http://www.uspreventiveservicestaskforce.org/uspstf07/hiv/hivrevup.pdf]

103.

Prendergast A, Mphatswe W, Tudor-Williams G, Rakgotho M, Pillay V, Thobakgale C, McCarthy N, Morris L, Walker BD, Goulder P: Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants. AIDS. 2008, 22: 1333-1343. 10.1097/QAD.0b013e32830437df.CrossRefPubMed

104.

Cleary SM, McIntyre D, Boulle AM: The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa - a primary data analysis. Cost Eff Resour Alloc. 2006, 4: 20-10.1186/1478-7547-4-20.CrossRefPubMedPubMedCentral

105.

Sohn AH, Thanh TC, Thinh le Q, Khanh TH, Thu HK, Giang le T, Lien TX: Failure of human immunodeficiency virus enzyme immunoassay to rule out infection among polymerase chain reaction-negative Vietnamese infants at 12 months of age. Pediatr Infect Dis J. 2009, 28: 273-276. 10.1097/INF.0b013e31818e03b4.CrossRefPubMedPubMedCentral

106.

Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group: Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission. AIDS. 2005, 19: 309-318.PubMedPubMedCentral

107.

Mphatswe W, Blanckenberg N, Tudor-Williams G, Prendergast A, Thobakgale C, Mkhwanazi N, McCarthy N, Walker BD, Kiepiela P, Goulder P: High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis. AIDS. 2007, 21: 1253-1261. 10.1097/QAD.0b013e3281a3bec2.CrossRefPubMed

108.

Mofenson LM, Korelitz J, Meyer WA, Bethel J, Rich K, Pahwa S, Moye J, Nugent R, Read J: The relationship between serum human immunodeficiency virus type 1 (HIV-1) RNA level, CD4 lymphocyte percent, and long-term mortality risk in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J Infect Dis. 1997, 175: 1029-1038. 10.1086/516441.CrossRefPubMed

109.

Shearer WT, Quinn TC, LaRussa P, Lew JF, Mofenson L, Almy S, Rich K, Handelsman E, Diaz C, Pagano M, Smeriglio V, Kalish LA: Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med. 1997, 336: 1337-1342. 10.1056/NEJM199705083361901.CrossRefPubMed

110.

Braun M, Kabue MM, McCollum ED, Ahmed S, Kim M, Aertker L, Chirwa M, Eliya M, Mofolo I, Hoffman I, Kazembe PN, van der Horst C, Kline MW, Hosseinipour MC: Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011.

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1741-7015/9/59/prepub

Title: Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions
Authors: Andrea L Ciaranello
Ji-Eun Park
Lynn Ramirez-Avila
Kenneth A Freedberg
Rochelle P Walensky
Valeriane Leroy
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: BMC Medicine / Issue 1/2011
Electronic ISSN: 1741-7015
DOI: https://doi.org/10.1186/1741-7015-9-59

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Early infant HIV-1 diagnosis programs in resource-limited settings: opportunities for improved outcomes and more cost-effective interventions

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2011

Closed-loop insulin delivery for treatment of type 1 diabetes

Even low level of physical activity is associated with reduced mortality among people with metabolic syndrome, a population based study (the HUNT 2 study, Norway)

A systematic review on the effect of sweeteners on glycemic response and clinically relevant outcomes

Clinical trials for stem cell therapies

Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science

Friedreich's ataxia: the vicious circle hypothesis revisited